Singapore, Sept. 4 -- There is a particular energy that settles over the Bangkok International Trade and Exhibition Centre (BITEC) in the first week of September, and this year it was unmistakable. Th... Read More
Singapore, Sept. 4 -- Singapore has spent decades building the foundations of a global biomedical hub. The more difficult task now is not to simply fund more science or attract more multinational inve... Read More
Singapore, Sept. 3 -- Students will have new opportunities to study across Melbourne and Indonesia with three dual degree programmes launched by the University of Melbourne and Universitas Gadjah Mada... Read More
Singapore, Sept. 3 -- Biocytogen Pharmaceuticals (Beijing) has entered into a non-exclusive licensing agreement with Qilu Pharmaceutical for a fully human VHH antibody molecule. Under the agreement, B... Read More
Singapore, Sept. 3 -- PharmaEssentia USA Corporation, a subsidiary of Taiwan-based PharmaEssentia Corporation, has announced that the US Food and Drug Administration (FDA) has approved BESREMi(R) (rop... Read More
Singapore, Sept. 2 -- Thailand LAB INTERNATIONAL 2026 kicks off today at the Bangkok International Trade & Exhibition Centre (BITEC), bringing together the laboratory, biotechnology, chemicals and lif... Read More
Singapore, Sept. 2 -- "Almost every company preparing for a partnering conversation prepares for the wrong gate. The rejection usually happens earlier in the process than founders imagine, and for rea... Read More
Singapore, Sept. 2 -- Cross-border partnership is usually discussed as two parties meeting in the middle. The more accurate picture is a structure with one engineered end and one improvised end, and S... Read More
Singapore, Sept. 2 -- Ascletis Pharma has dosed the first participant in its global Phase III clinical programme evaluating ASC30, an investigational once-daily oral small molecule GLP-1 receptor agon... Read More
Singapore, Sept. 2 -- Singapore has become the first ASEAN country to provide government subsidies for eligible patients receiving vutrisiran for transthyretin amyloidosis. From 1 September 2026, vut... Read More